Linkedin Twitter

H2020-IMI2-2020-20-04: Tumour Plasticity

Deadline: 2020-11-19 Status: Closed
Description
The overall objective of the Call topic is to use state-of-the-art single-cell sequencing to understand and overcome drug resistance in cancer by characterising the biology of drug tolerant persister cells, building the capability for such studies across Europe. The call topic will address primarily adult tumours, with the provision to include childhood tumours where appropriate models are available at a later stage of the programme. Type of action: Research and Innovation Action.

THIS GRANT IS CURRENTLY CLOSED. SEARCH OTHER FUNDING OPPORTUNITIES OR REGISTER TO ACCESS ALL THE INFORMATION AND R&D PROJECTS OPPORTUNITIES IN YOUR AREAS OF INTEREST